A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
Objective: To compare the effects of intravenous hyoscine butylbromide versus placebo on the duration of labor in term pregnancies. Materials and methods: 86 patients were selected and randomly assigned to receive intravenous hyoscine butylbromide (20 mg twice) (n = 43) or an intravenous placebo (saline solution 10 cc) (n = 43). We evaluated maternal adverse effects, effects on neonatal Apgar score, cervical dilatation 1 h after drug administration and the interval between the onset of labordoi:10.1016/j.rmu.2015.01.001 fatcat:jqnzcakfsvh33hqiroklklrzsm